Controlled Buisness

Controlled business in insurance refers to the business that an insurance agent or broker places with the insurer that they are affiliated with. The term "controlled" implies that the agent or broker has some degree of control over the business that they place with their affiliated insurer.

Here are some key features of controlled business in insurance:

• Affiliation: Controlled business arises from the relationship between an insurance agent or broker and the insurer that they are affiliated with.

• Incentives: Agents or brokers may be incentivized to place more business with their affiliated insurer through various means such as higher commissions, bonuses, or other rewards.

• Regulation: The insurance industry is heavily regulated, and regulators are particularly concerned about controlled business because it may create conflicts of interest that could harm consumers.

• Disclosure: To address these concerns, regulators may require agents and brokers to disclose their affiliations with insurers and any incentives that they receive for placing business with a particular insurer.

For example, an insurance agent may be affiliated with an insurer and receive a higher commission for placing business with that insurer. The agent may have some degree of control over the business they place with that insurer, such as steering clients towards that insurer or offering incentives to clients to purchase policies from that insurer. Regulators may require the agent to disclose their affiliation and any incentives that they receive to ensure transparency and protect consumers.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.